Buprenorphine vs Durvalumab

## Buprenorphine vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Buprenorphine** and **Durvalumab**.

## Mechanism of Action

**Buprenorphine**: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Buprenorphine — 24-42 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Buprenorphine — C29H41NO4; Durvalumab — N/A.

**Molecular Weight**: Buprenorphine — 467.6430 g/mol; Durvalumab — N/A.

**Type**: Buprenorphine — Small molecule; Durvalumab — Antibody.